Summary
Updated Aug 30, 2026
Christopher Mutz is HEAD OF RARE DISEASE of ANI PHARMACEUTICALS INC (ANIP). 9 SEC Form 4 filings on record going back to 2024, most recently on 13 March 2026. Most recent open-market trade: sold $227K of ANIP on 13 March 2026. Lifetime open-market sales: $2.25M.
Recent Transactions
14Every recent SEC Form 4 transaction Christopher Mutz has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Christopher Mutz go back to 2024: 9 primary Form 4 filings, an average of 3.0 per year. 9 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher Mutz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nikhil Lalwani - $4.67M of ANIP open-market activity in the last 12 months
- Patrick D. Walsh - $2.32M of ANIP open-market activity in the last 12 months
- Stephen P. Carey - $1.57M of ANIP open-market activity in the last 12 months
- Chad Gassert - $1.31M of ANIP open-market activity in the last 12 months
- Krista Davis - $883K of ANIP open-market activity in the last 12 months
- Antonio R. Pera - $692K of ANIP open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Christopher Mutz?
Christopher Mutz is a corporate insider, tracked as HEAD OF RARE DISEASE of ANI PHARMACEUTICALS INC (ANIP). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Christopher Mutz last file a Form 4?
The most recent primary Form 4 on record is dated 13 March 2026, one of 9 filings going back to 2024.
Has Christopher Mutz been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($2.25M) across all tracked filings.
Where can I see all of Christopher Mutz's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Christopher Mutz and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial